1972
DOI: 10.1016/s0016-5085(72)80157-4
|View full text |Cite
|
Sign up to set email alerts
|

Erythema Multiforme and Crohn's Disease of the Large Intestine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

1976
1976
2019
2019

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(5 citation statements)
references
References 8 publications
0
5
0
Order By: Relevance
“…43,44 Oral tacrolimus therapy seems to be associated with short-and long-term benefits 45 and may represent a therapeutic option in CD when conventional therapies fail. Tables 1 and 2) Reactive (immune-related) lesions secondary to CD Pyoderma gangrenosum 155,156 Erythema nodosum 156 Erythema multiforme 157,158 Finger clubbing 159 Palmar erythema 6 Rosacea-like eruption 160 Pyoderma faciale 161 Epidermolysis bullosa acquisita 162 Secondary systemic amyloidosis 163 Vitiligo 95,164 Palmo-plantar pustulosis 165 Sweet's syndrome 166 Lesions from nutritional deficiencies Acrodermatitis enteropathica-like syndrome (acquired zinc deficiency) 167 Marasmic striae 6 Infliximab has been used with success for treatment of extra-intestinal manifestations of CD. [46][47][48] There are four successfully treated cases of MCD; [49][50][51][52] one of them uses a combination of infliximab with methotrexate.…”
Section: Treatmentmentioning
confidence: 99%
“…43,44 Oral tacrolimus therapy seems to be associated with short-and long-term benefits 45 and may represent a therapeutic option in CD when conventional therapies fail. Tables 1 and 2) Reactive (immune-related) lesions secondary to CD Pyoderma gangrenosum 155,156 Erythema nodosum 156 Erythema multiforme 157,158 Finger clubbing 159 Palmar erythema 6 Rosacea-like eruption 160 Pyoderma faciale 161 Epidermolysis bullosa acquisita 162 Secondary systemic amyloidosis 163 Vitiligo 95,164 Palmo-plantar pustulosis 165 Sweet's syndrome 166 Lesions from nutritional deficiencies Acrodermatitis enteropathica-like syndrome (acquired zinc deficiency) 167 Marasmic striae 6 Infliximab has been used with success for treatment of extra-intestinal manifestations of CD. [46][47][48] There are four successfully treated cases of MCD; [49][50][51][52] one of them uses a combination of infliximab with methotrexate.…”
Section: Treatmentmentioning
confidence: 99%
“…The combination of positive anti-Saccharomyces cerevisiae antibodies and negative perinuclear ANCA, as seen in this patient, has a reported 96% positive predictive value for Crohn's disease, 8 (Table 1), [11][12][13] although one of these patients developed targetoid lesions after infliximab administration 11 Although HSV is the most likely trigger, given its overall prevalence in adolescent erythema multiforme, unique aspects of this case (continued activity despite compliance with valacyclovir, negative PCR, unusual presentation with prominent lip edema and bullae on the back) suggest a complex immunologic interplay between Crohn's, orofacial granulomatosis, and erythema multiforme. Erythema multiforme itself can occur as a true cytotoxic autoimmune type IV immune response to keratinocytes, best exemplified by the erythema multiforme-like reactions in Rowell's syndrome.…”
Section: Case Presentationmentioning
confidence: 58%
“…Although uncommon, erythema multiforme has been reported in association with IBD, although most of these cases occurred in patients with ulcerative colitis . A PubMed search of articles indexed for MEDLINE using the terms Crohn's, Crohn's disease, inflammatory bowel disease, and erythema multiforme revealed three isolated case reports of erythema multiforme in association with Crohn's disease (Table ), although one of these patients developed targetoid lesions after infliximab administration and one after sulfasalazine, perhaps suggesting medication‐induced erythema multiforme.…”
Section: Discussionmentioning
confidence: 99%
“…Crohn's disease's histopathology is marked by inflammation, edema, granulomas, and giant cells. Many cutaneous conditions have been associated frequently and episodically with CD (Table 1) (4–23).…”
Section: Discussionmentioning
confidence: 99%